Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP46974.RAdJ7jOEjsU6nqLyTd4T4zC1Ax3VrQ4d_yMaS47fsvGOs130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP46974.RAdJ7jOEjsU6nqLyTd4T4zC1Ax3VrQ4d_yMaS47fsvGOs130_provenance.
• NP49743.RAV0wyqNEwfe46nnxokQze1BosZP3ser7Ekm0wVkzt7Og130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP49743.RAV0wyqNEwfe46nnxokQze1BosZP3ser7Ekm0wVkzt7Og130_provenance.
• NP49758.RASMCjdIu0ICiXpTLLXpg_bvNQQymghZtjLvBxAtcGj_Q130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP49758.RASMCjdIu0ICiXpTLLXpg_bvNQQymghZtjLvBxAtcGj_Q130_provenance.
• NP46973.RA3LyYSmpPimFyVBLH1OuparGIF6HCVo_3l9NGPubMvSE130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP46973.RA3LyYSmpPimFyVBLH1OuparGIF6HCVo_3l9NGPubMvSE130_provenance.
• NP60084.RAe5vMtNbBobdOGhORMyJxyYmiCjnHEcqJcQGmS9ZnQRo130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP60084.RAe5vMtNbBobdOGhORMyJxyYmiCjnHEcqJcQGmS9ZnQRo130_provenance.
• NP62303.RAXdlayZhQa5MhCuoGzuR70DY9CrwhprNhdZZke2vsMwo130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62303.RAXdlayZhQa5MhCuoGzuR70DY9CrwhprNhdZZke2vsMwo130_provenance.
• NP59372.RAiVIqVdCsL7eiqAojEBiLA0o2dcqqBbAVoJqz7IOr70M130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59372.RAiVIqVdCsL7eiqAojEBiLA0o2dcqqBbAVoJqz7IOr70M130_provenance.
• NP62458.RAn5GE35jp4Bsk8S8JQTAFE39pT3XMnV1svBQywMghnCM130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62458.RAn5GE35jp4Bsk8S8JQTAFE39pT3XMnV1svBQywMghnCM130_provenance.
• NP60156.RAMfoxrZtnPXbqEjd6Awn2d2eMqSC54N_OUYkuFCsYhUQ130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to assess relationships between irinotecan disposition and the rare variant genotypes, especially in other ethnic groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP60156.RAMfoxrZtnPXbqEjd6Awn2d2eMqSC54N_OUYkuFCsYhUQ130_provenance.